These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 20967826)

  • 21. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition.
    Chen Y; Ou Y; Dong J; Yang G; Zeng Z; Liu Y; Liu B; Li W; He X; Lan T
    Exp Cell Res; 2018 Jan; 362(2):343-348. PubMed ID: 29196165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH).
    Hartimath SV; Boominathan R; Soh V; Cheng P; Deng X; Chong YC; Yong FF; Tan PW; Han W; Robins EG; Goggi JL
    Contrast Media Mol Imaging; 2019; 2019():6298128. PubMed ID: 31866798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study on roles of natural killer T cells in two diet-induced non-alcoholic steatohepatitis-related fibrosis in mice.
    Zheng S; Yang W; Yao D; Tang S; Hou J; Chang X
    Ann Med; 2022 Dec; 54(1):2233-2245. PubMed ID: 35950602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis.
    Zhu C; Kim K; Wang X; Bartolome A; Salomao M; Dongiovanni P; Meroni M; Graham MJ; Yates KP; Diehl AM; Schwabe RF; Tabas I; Valenti L; Lavine JE; Pajvani UB
    Sci Transl Med; 2018 Nov; 10(468):. PubMed ID: 30463916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
    Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
    Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
    J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Procyanidin B2 inhibits the activation of hepatic stellate cells and angiogenesis via the Hedgehog pathway during liver fibrosis.
    Feng J; Wang C; Liu T; Li J; Wu L; Yu Q; Li S; Zhou Y; Zhang J; Chen J; Ji J; Chen K; Mao Y; Wang F; Dai W; Fan X; Wu J; Guo C
    J Cell Mol Med; 2019 Sep; 23(9):6479-6493. PubMed ID: 31328391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice.
    Tomita K; Teratani T; Suzuki T; Shimizu M; Sato H; Narimatsu K; Okada Y; Kurihara C; Irie R; Yokoyama H; Shimamura K; Usui S; Ebinuma H; Saito H; Watanabe C; Komoto S; Kawaguchi A; Nagao S; Sugiyama K; Hokari R; Kanai T; Miura S; Hibi T
    Hepatology; 2014 Jan; 59(1):154-69. PubMed ID: 23832448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model.
    Hayashida M; Hashimoto K; Ishikawa T; Miyamoto Y
    Int J Exp Pathol; 2019 Apr; 100(2):72-82. PubMed ID: 30887659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
    Nguyen G; Park SY; Le CT; Park WS; Choi DH; Cho EH
    Biochem Biophys Res Commun; 2018 Jan; 495(4):2649-2656. PubMed ID: 29278707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-β1/Smad signaling pathway.
    Ni XX; Li XY; Wang Q; Hua J
    J Physiol Biochem; 2021 Feb; 77(1):35-45. PubMed ID: 33188625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis.
    Dixon LJ; Berk M; Thapaliya S; Papouchado BG; Feldstein AE
    Lab Invest; 2012 May; 92(5):713-23. PubMed ID: 22411067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
    Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
    Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteopontin: Versatile modulator of liver diseases.
    Nagoshi S
    Hepatol Res; 2014 Jan; 44(1):22-30. PubMed ID: 23701387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells.
    Kim M; Yang SG; Kim JM; Lee JW; Kim YS; Lee JI
    Int J Mol Med; 2012 Sep; 30(3):473-9. PubMed ID: 22710359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caspase 3 inactivation protects against hepatic cell death and ameliorates fibrogenesis in a diet-induced NASH model.
    Thapaliya S; Wree A; Povero D; Inzaugarat ME; Berk M; Dixon L; Papouchado BG; Feldstein AE
    Dig Dis Sci; 2014 Jun; 59(6):1197-206. PubMed ID: 24795036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Annexin A1 treatment prevents the evolution to fibrosis of experimental nonalcoholic steatohepatitis.
    Gadipudi LL; Ramavath NN; Provera A; Reutelingsperger C; Albano E; Perretti M; Sutti S
    Clin Sci (Lond); 2022 May; 136(9):643-656. PubMed ID: 35438166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice.
    Du M; Wang X; Yuan L; Liu B; Mao X; Huang D; Yang L; Huang K; Zhang F; Wang Y; Luo X; Wang C; Peng J; Liang M; Huang D; Huang K
    J Hepatol; 2020 Dec; 73(6):1333-1346. PubMed ID: 32717288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic stellate cells-specific LOXL1 deficiency abrogates hepatic inflammation, fibrosis, and corrects lipid metabolic abnormalities in non-obese NASH mice.
    Yang A; Yan X; Fan X; Shi Y; Huang T; Li W; Chen W; Jia J; You H
    Hepatol Int; 2021 Oct; 15(5):1122-1135. PubMed ID: 34014450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice.
    Itagaki H; Shimizu K; Morikawa S; Ogawa K; Ezaki T
    Int J Clin Exp Pathol; 2013; 6(12):2683-96. PubMed ID: 24294355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.